Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joost Raaphorst

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 27, 2017
A case series of PLS patients with frontotemporal dementia and overview of the literatureBálint S de Vries, Laura M M Rustemeijer, Anneke J van der Kooi, et al.
Journal of Neurology|May 15, 2026
Associations of cognitive and behavioural impairment in ALS with brain pathology: pTDP-43 versus microglial activationHanneke M J Slaghekke, Rosanne Govaarts, Lucia Mesarosova, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 15, 2020
Progression of cognitive and behavioural impairment in early amyotrophic lateral sclerosisEmma Beeldman, Rosanne Govaarts, Marianne de Visser, et al.
Journal of Alzheimer'S Disease : JAD|September 24, 2016
Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot StudyH Bea Kuiperij, Alexandra A M Versleijen, Marijke Beenes, et al.
Seminars in Arthritis and Rheumatism|August 19, 2024
Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working groupEllen Romich, Didem Saygin, Dana DiRenzo, et al.
Neurology|August 1, 2014
Prefrontal involvement related to cognitive impairment in progressive muscular atrophyJoost Raaphorst, Marie-José van Tol, Paul F C Groot, et al.
Seminars in Arthritis and Rheumatism|June 8, 2024
The impact of pain on daily activities in patients with idiopathic inflammatory myopathies: Report from the OMERACT myositis working groupDidem Saygin, Helene Alexanderson, Dana DiRenzo, et al.
Journal of Neuromuscular Diseases|January 23, 2023
Multimodality Screening For (Peri)Myocarditis In Newly Diagnosed Idiopathic Inflammatory Myopathies: A Cross-Sectional StudyJohan Lim, Hannah A W Walter, Rianne A C M de Bruin-Bon, et al.
Rheumatology (Oxford, England)|November 2, 2022
B-cell receptor profiling before and after IVIG monotherapy in newly diagnosed idiopathic inflammatory myopathiesDornatien C Anang, Hannah A W Walter, Johan Lim, et al.
BMC Neurology|April 17, 2015
Combined N-of-1 trials to investigate mexiletine in non-dystrophic myotonia using a Bayesian approach; study rationale and protocolBas C Stunnenberg, Willem Woertman, Joost Raaphorst, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 27, 2017
A case series of PLS patients with frontotemporal dementia and overview of the literatureBálint S de Vries, Laura M M Rustemeijer, Anneke J van der Kooi, et al.
Journal of Neurology|May 15, 2026
Associations of cognitive and behavioural impairment in ALS with brain pathology: pTDP-43 versus microglial activationHanneke M J Slaghekke, Rosanne Govaarts, Lucia Mesarosova, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 15, 2020
Progression of cognitive and behavioural impairment in early amyotrophic lateral sclerosisEmma Beeldman, Rosanne Govaarts, Marianne de Visser, et al.
Journal of Alzheimer'S Disease : JAD|September 24, 2016
Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot StudyH Bea Kuiperij, Alexandra A M Versleijen, Marijke Beenes, et al.
Seminars in Arthritis and Rheumatism|August 19, 2024
Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working groupEllen Romich, Didem Saygin, Dana DiRenzo, et al.
Neurology|August 1, 2014
Prefrontal involvement related to cognitive impairment in progressive muscular atrophyJoost Raaphorst, Marie-José van Tol, Paul F C Groot, et al.
Seminars in Arthritis and Rheumatism|June 8, 2024
The impact of pain on daily activities in patients with idiopathic inflammatory myopathies: Report from the OMERACT myositis working groupDidem Saygin, Helene Alexanderson, Dana DiRenzo, et al.
Journal of Neuromuscular Diseases|January 23, 2023
Multimodality Screening For (Peri)Myocarditis In Newly Diagnosed Idiopathic Inflammatory Myopathies: A Cross-Sectional StudyJohan Lim, Hannah A W Walter, Rianne A C M de Bruin-Bon, et al.
Rheumatology (Oxford, England)|November 2, 2022
B-cell receptor profiling before and after IVIG monotherapy in newly diagnosed idiopathic inflammatory myopathiesDornatien C Anang, Hannah A W Walter, Johan Lim, et al.
BMC Neurology|April 17, 2015
Combined N-of-1 trials to investigate mexiletine in non-dystrophic myotonia using a Bayesian approach; study rationale and protocolBas C Stunnenberg, Willem Woertman, Joost Raaphorst, et al.
Pageof 9